GlassScriptPhysician profile
Nickolay Peter Markov
NPI 1598927824
$2,598.01
in general payments reported to CMS, 2019-2025
8 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.11 · 2021: $171 · 2022: $312 · 2023: $182 · 2024: $1,464 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479 · Travel and Lodging: $562 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.89 |
| Travel and Lodging | $561.73 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,725.75 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Mentor Worldwide LLC | $303.58 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $267.20 | 2020-2022 | |
| Polynovo North America LLC | $90.28 | 2022 | |
| Tela Bio, INC. | $84.60 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Solventum Corporation | $61.40 | 2025 | Prevena Restor Bellaform, V.A.C. Veraflo, V.A.C.Ulta |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Boston Scientific Corporation | $21.95 | 2023 | Intellanav Mifi Xp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickolay Markov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.